Verdict Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

The FDA’s view – Dr Jeffrey Shuren

In recent months the medical device industry has been critical of what it says is a growing delay in the time it takes to get new products to market in the US. In November 2011, Dr Jeffrey Shuren, director of the Center for Devices and Radiological Health at the FDA, testified in front of the US Senate Committee on Health, Education, Labor and Pensions about the pre-market review process, and the agency's work to reduce delays and improve clarity. Here are highlights from his testimony.

Go Top